{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:03:14Z","timestamp":1779951794833,"version":"3.53.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This research is designed to establish a prognostic framework derived from m6A- and autophagy-related lncRNAs (m6aARLncs) to enhance survival prediction in esophageal squamous cell carcinoma (ESCC). Concurrently, it endeavors to elucidate the role of prognostic framework in modulating the tumor immune microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Transcriptomic data from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) were employed as the training and independent validation cohorts, respectively. m6A-related genes (m6aRGs) and autophagy-related genes (ARGs) were curated from published literature and the Human Autophagy Database (HADb), respectively. Subsequently, differentially expressed m6aARLncs (DE-m6aARLncs) were identified by integrating co-expression analysis with differential expression profiling. A prognostic risk signature was constructed using univariate Cox and LASSO regression analyses. The model\u2019s predictive efficacy was rigorously validated through risk heatmap, survival analysis, ROC curves, differential analysis and independent prognostic analysis. Furthermore, the association between riskScores and clinical features was assessed. To elucidate the model\u2019s biological relevance, Gene Set Enrichment Analysis (GSEA) was performed. The impact of the risk signature on the tumor immune microenvironment was comprehensively evaluated via tumor microenvironment analysis, immune cell correlation analysis, single-sample gene set enrichment analysis (ssGSEA), and immune checkpoint profiling. Single-cell sequencing data analysis was carried out. Drug sensitivity profiling was conducted to identify putative therapeutic agents tailored to distinct risk subgroups. The putative m6A-autophagy-lncRNA regulatory axis may implicated in ESCC pathogenesis was proposed. Finally, the mRNA expression levels of m6aARLncs were validated using reverse transcription quantitative polymerase chain reaction (RT-qPCR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We established a robust risk prognostic model based on five m6aARLncs (LINC00847, UBL7-AS1, LINC01554, LINC00601, and FAM222A-AS1), which demonstrated significant efficacy in predicting overall survival in ESCC patients. Comprehensive immune profiling delineated the unique immune phenotype of the prognostic model, characterized by the infiltration of mast cells, B cells, neutrophils, plasmacytoid dendritic cells (pDCs), helper T cells, and tumor-infiltrating lymphocytes (TILs), as well as human leukocyte antigens (HLA), etc. The B cells, neutrophils and dendritic cells identified by immune microenvironment analysis results may have been verified to some extent through single-cell sequencing analysis. Furthermore, the expression of two immune checkpoint molecules, TNFRSF18 and LAIR1, was significantly correlated with risk stratification, suggesting their potential therapeutic relevance. Pharmacogenomic analysis identified nine compounds (Shikonin, Bicalutamide, Bryostatin-1, Epothilone-B, JNK-9L, LFM-A13, QS11, VX-680, and Z-LLNle-CHO) exhibiting differential sensitivity between the dichotomous risk strata. We propose novel m6A-autophagy-lncRNA regulatory axis implicating the 5 m6aARLncs, 5 m6aRGs and 21 ARGs, which may play a pivotal role in ESCC pathogenesis. Finally, the results of RT-qPCR verification indicated that the expressions of FAM222A-AS1, LINC00601, LINC00847, LINC01554 and UBL7-AS1 were upregulated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study yields findings that hold significant clinical implications for refining prognostic stratification and deciphering the immune landscape in ESCC. Moreover, they offer novel perspectives that may pave the way for more precise prognostic assessment and the formulation of targeted therapeutic interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1766278","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:20:45Z","timestamp":1779949245000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of an m6A and autophagy related lncRNAs signature for predicting survival and modulating the immune microenvironment in esophageal squamous cell carcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Mingyi","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Joint Surgery, HongHui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghao","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Joint Surgery, HongHui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Tangdu Hospital, The Fourth Military Medical University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Joint Surgery, HongHui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Joint Surgery, HongHui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjie","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Joint Surgery, HongHui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Joint Surgery, HongHui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Joint Surgery, HongHui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Practice, Honghui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Joint Surgery, HongHui Hospital, Xi\u2019an Jiaotong University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Tangdu Hospital, The Fourth Military Medical University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1303068","article-title":"Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma","volume":"14","author":"Xie","year":"2024","journal-title":"Front Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-22-2593","article-title":"Intratumoral microbiota composition regulates chemoimmunotherapy response in esophageal squamous cell carcinoma","volume":"83","author":"Wu","year":"2023","journal-title":"Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000002768","article-title":"Advances in targeted therapy and immunotherapy for esophageal cancer","volume":"136","author":"Yang","year":"2023","journal-title":"Chin Med J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1423629","article-title":"Metabolic reprogramming in esophageal squamous cell carcinoma","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146701","article-title":"From detection to prediction: Advances in m6A methylation analysis through machine learning and deep learning with implications in cancer","volume":"26","author":"Jin","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","article-title":"The role of m6A methylation in therapy resistance in cancer","volume":"22","author":"Zhuang","year":"2023","journal-title":"Mol Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14205139","article-title":"The role of m(6)A modification and m(6)A regulators in esophageal cancer","volume":"14","author":"Li","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13578-023-01148-7","article-title":"SHMT2 regulates esophageal cancer cell progression and immune escape by mediating m6A modification of c-myc","volume":"13","author":"Qiao","year":"2023","journal-title":"Cell Biosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.21203\/rs.3.rs-907813\/v1","article-title":"m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer","volume":"12","author":"Duan","year":"2022","journal-title":"Cell Bioscience"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-1138-4","article-title":"Autophagy and autophagy-related proteins in cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189302","article-title":"Radiotherapy modulates autophagy to reshape the tumor immune microenvironment to enhance anti-tumor immunity in esophageal cancer","volume":"1880","author":"Zhou","year":"2025","journal-title":"Biochim Biophys Acta (BBA) - Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12876-022-02421-8","article-title":"Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1599171","article-title":"Characterization of novel anoikis-related genes as prognostic biomarkers and key determinants of the immune microenvironment in esophageal cancer","volume":"16","author":"Su","year":"2025","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.763027","article-title":"Identification of a N6-methyladenosine (m6A)-related lncRNA signature for predicting the prognosis and immune landscape of lung squamous cell carcinoma","volume":"11","author":"Weng","year":"2021","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.5114\/aoms\/171672","article-title":"LINC00847 drives pancreatic cancer progression by targeting the miR-455-3p\/HDAC4 axis","volume":"20","author":"Hao","year":"2024","journal-title":"Arch Med Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.663558","article-title":"Long non-coding RNA LINC00847 induced by E2F1 accelerates non-small cell lung cancer progression through targeting miR-147a\/IFITM1 axis","volume":"8","author":"Li","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2174\/1386207326666230816113411","article-title":"LncRNA LINC00847 accelerates melanoma progression by regulating miR-133a-3p\/TGFBR1 axis","volume":"27","author":"Jiang","year":"2024","journal-title":"Comb Chem High Throughput Screening"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2623599","DOI":"10.1155\/2022\/2623599","article-title":"Therapy\u2010resistant and \u2010sensitive lncRNAs, SNHG1 and UBL7\u2010AS1 promote glioblastoma cell proliferation","volume":"2022","author":"Cao","year":"2022","journal-title":"Oxid Med Cell Longevity"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7150\/jca.40512","article-title":"Down-regulation of long non-coding RNA LINC01554 in hepatocellular cancer and its clinical significance","volume":"11","author":"Ding","year":"2020","journal-title":"J Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27319","article-title":"Long non-coding RNA LINC01554 overexpression suppresses viability, migration, and invasion of liver cancer cells through regulating miR-148b-3p\/EIF4E3","volume":"10","author":"Ren","year":"2024","journal-title":"Heliyon"},{"key":"B22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12935-025-03735-9","article-title":"LINC00601 promotes the progression of glioma via the p-STAT3 signaling pathway","volume":"25","author":"Ma","year":"2025","journal-title":"Cancer Cell Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.764621","article-title":"The long non-coding RNA FAM222A-AS1 negatively modulates miR-let-7f to promote colorectal cancer progression","volume":"12","author":"Song","year":"2022","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00262-024-03914-z","article-title":"SUMO modified ETV1 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by facilitating CCL2 transcription in esophageal squamous cell carcinoma cells","volume":"74","author":"Han","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41388-023-02923-z","article-title":"The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis","volume":"43","author":"Zhou","year":"2024","journal-title":"Oncogene"},{"key":"B26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-022-02348-8","article-title":"Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK\/STAT3 pathway","volume":"41","author":"Sun","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1460-4","article-title":"Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma","volume":"62","author":"Wang","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2050.2001.00171.x","article-title":"Association of mast cells with tumor angiogenesis in esophageal squamous cell carcinoma","volume":"14","author":"Tomita","year":"2001","journal-title":"Dis Esophagus"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-7","article-title":"The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma","volume":"12","author":"Wang","year":"2014","journal-title":"J Transl Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-025-02286-0","article-title":"Investigating tumor-infiltrating lymphocytes as predictors of lymph node metastasis in deep submucosal invasive esophageal squamous cell carcinoma: a retrospective cross-sectional study","volume":"60","author":"Konishi","year":"2025","journal-title":"J Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02712-9","article-title":"HLA-A+ tertiary lymphoid structures with reactivated tumor infiltrating lymphocytes are associated with a positive immunotherapy response in esophageal squamous cell carcinoma","volume":"131","author":"Zhang","year":"2024","journal-title":"Br J Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70179","article-title":"Prognostic value of tumor-infiltrating lymphocytes and PD-L1 expression in esophageal squamous cell carcinoma","volume":"13","author":"Hu","year":"2024","journal-title":"Cancer Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1590\/s0100-879x2011000500006","article-title":"Novel regulatory SNPs in the promoter region of the TNFRSF18 gene in a Gabonese population","volume":"44","author":"Velavan","year":"2011","journal-title":"Braz J Med Biol Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2018.04.046","article-title":"miR-146a-5p promotes replication of infectious bronchitis virus by targeting IRAK2 and TNFRSF18","volume":"120","author":"Liu","year":"2018","journal-title":"Microb Pathog"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2020.1740477","article-title":"Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1","volume":"9","author":"Xu","year":"2020","journal-title":"OncoImmunology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1038\/s41467-020-18298-8","article-title":"Collagen promotes anti-PD-1\/PD-L1 resistance in cancer through LAIR1-dependent CD8(+) T cell exhaustion","volume":"11","author":"Peng","year":"2020","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12885-025-13692-1","article-title":"Mechanistic role of FN1 in LAIR-1 mediated downregulation of ovarian cancer cell proliferation","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10662","article-title":"Shikonin potentiates paclitaxel antitumor efficacy in esophageal cancer cells via the apoptotic pathway","volume":"18","author":"Du","year":"2019","journal-title":"Oncol Lett"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/7752299","article-title":"Shikonin induces autophagy and apoptosis in esophageal cancer EC9706 cells by regulating the AMPK\/mTOR\/ULK axis","volume":"2024","author":"Zhang","year":"2024","journal-title":"Anal Cell Pathol (Amst)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"10094","DOI":"10.1038\/s41598-021-89609-2","article-title":"Abiraterone acetate versus bicalutamide in combination with gonadotropin releasing hormone antagonist therapy for high risk metastatic hormone sensitive prostate cancer","volume":"11","author":"Ueda","year":"2021","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2024.102530","article-title":"Bicalutamide reveals immunomodulatory effects in prostate cancer by regulating immunogenic dendritic cell maturation","volume":"91","author":"Nourbakhsh","year":"2024","journal-title":"Tissue Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.2010.09726.x","article-title":"Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health\u2010related quality of life benefits for osteoporotic men with prostate cancer","volume":"107","author":"Wadhwa","year":"2010","journal-title":"BJU Int"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601321","article-title":"A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer","volume":"89","author":"MadhuSudan","year":"2003","journal-title":"Br J Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1124\/mol.110.064741","article-title":"Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) \u03b4 translocation and preventing PKC\u03b4-mediated release of tumor necrosis factor-\u03b1","volume":"78","author":"von Burstin","year":"2010","journal-title":"Mol Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-008-0677-y","article-title":"Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer","volume":"62","author":"Ku","year":"2008","journal-title":"Cancer Chemotherapy Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-016-2236-y","article-title":"Epothilone B induces apoptosis and enhances apoptotic effects of ABT-737 on human cancer cells via PI3K\/AKT\/mTOR pathway","volume":"142","author":"Li","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2015.01.023","article-title":"Epothilone B induces human ovarian cancer OV-90 cell apoptosis via external pathway","volume":"39","author":"Rogalska","year":"2015","journal-title":"Environ Toxicol Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-8140(03)00200-7","article-title":"Potential radiation-sensitizing effect of semisynthetic epothilone B in human lung cancer cells","volume":"68","author":"Kim","year":"2003","journal-title":"Radiother Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2020.1818738","article-title":"The intensification of anticancer activity of LFM-A13 by erythropoietin as a possible option for inhibition of breast cancer","volume":"35","author":"Rozkiewicz","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy047.030","article-title":"Simultaneous use of erythropoietin and LFM\u2010A13 as a new therapeutic approach for colorectal cancer","volume":"175","author":"Tankiewicz\u2010Kwedlo","year":"2018","journal-title":"Br J Pharmacol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2015.06.062","article-title":"Structure\u2013activity relationship studies of QS11, a small molecule Wnt synergistic agonist","volume":"25","author":"Singh","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1677\/erc-08-0021","article-title":"Effects of the Aurora kinase inhibitor VX-680 on anaplastic thyroid cancer-derived cell lines","volume":"15","author":"Arlot-Bonnemains","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-016-0358-3","article-title":"The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line","volume":"34","author":"Pezzani","year":"2016","journal-title":"Invest New Drugs"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.50","article-title":"GSI-I (Z-LLNle-CHO) inhibits gamma-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia","volume":"25","author":"Meng","year":"2011","journal-title":"Leukemia"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1766278\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:20:46Z","timestamp":1779949246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1766278\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2026.1766278"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1766278","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1766278"}}